Search research articles
Contact Us
Filters
Showing results (461-470 of 504) with videos related to
Page
of 51
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
January 29, 2026
PET-Based Outcome Prediction in Patients with Prostate Cancer Scheduled for [<sup>225</sup>Ac]Ac-PSMA Radiopharmaceutical Therapy
Liam Widjaja, Sophie C Siegmund, Franz J Gildehaus, et al.
Clinical Nuclear Medicine
|
January 24, 2017
Defining the Added Value of 99mTc-MIBI SPECT/CT to Conventional Cross-Sectional Imaging in the Characterization of Enhancing Solid Renal Masses
Sara Sheikhbahaei, Christopher S Jones, Kristin K Porter, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
April 3, 2020
Appropriate Use Criteria for Imaging Evaluation of Biochemical Recurrence of Prostate Cancer After Definitive Primary Treatment
Hossein Jadvar, Leslie K Ballas, Peter L Choyke, et al.
Medical Oncology (Northwood, London, England)
|
April 28, 2022
Interim analysis of companion, prospective, phase II, clinical trials assessing the efficacy and safety of multi-modal total eradication therapy in men with synchronous oligometastatic prostate cancer
Diane K Reyes, Bruce J Trock, Phuoc T Tran, et al.
Diagnostics (Basel, Switzerland)
|
November 27, 2021
Whole-Body [<sup>18</sup>F]FDG PET/CT Can Alter Diagnosis in Patients with Suspected Rheumatic Disease
Matthias Fröhlich, Sebastian Serfling, Takahiro Higuchi, et al.
European Urology
|
March 19, 2023
Second Version of the Prostate Cancer Molecular Imaging Standardized Evaluation Framework Including Response Evaluation for Clinical Trials (PROMISE V2)
Robert Seifert, Louise Emmett, Steven P Rowe, et al.
Oncotarget
|
July 21, 2016
[64Cu]XYIMSR-06: A dual-motif CAIX ligand for PET imaging of clear cell renal cell carcinoma
Il Minn, Soo Min Koo, Hye Soo Lee, et al.
The Journal of Urology
|
February 26, 2021
A Phase 2/3 Prospective Multicenter Study of the Diagnostic Accuracy of Prostate Specific Membrane Antigen PET/CT with <sup>18</sup>F-DCFPyL in Prostate Cancer Patients (OSPREY)
Kenneth J Pienta, Michael A Gorin, Steven P Rowe, et al.
Journal of Imaging Informatics in Medicine
|
April 8, 2024
An Automated Deep Learning-Based Framework for Uptake Segmentation and Classification on PSMA PET/CT Imaging of Patients with Prostate Cancer
Yang Li, Maliha R Imami, Linmei Zhao, et al.
The Journal of Urology
|
April 15, 2021
Reply by Authors
Kenneth J Pienta, Michael A Gorin, Steven P Rowe, et al.
Page
of 51
Search research articles
Search
Showing results (461-470 of 504) with videos related to
Sort By:
Page
of 51
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
January 29, 2026
PET-Based Outcome Prediction in Patients with Prostate Cancer Scheduled for [<sup>225</sup>Ac]Ac-PSMA Radiopharmaceutical Therapy
Liam Widjaja, Sophie C Siegmund, Franz J Gildehaus, et al.
Clinical Nuclear Medicine
|
January 24, 2017
Defining the Added Value of 99mTc-MIBI SPECT/CT to Conventional Cross-Sectional Imaging in the Characterization of Enhancing Solid Renal Masses
Sara Sheikhbahaei, Christopher S Jones, Kristin K Porter, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
April 3, 2020
Appropriate Use Criteria for Imaging Evaluation of Biochemical Recurrence of Prostate Cancer After Definitive Primary Treatment
Hossein Jadvar, Leslie K Ballas, Peter L Choyke, et al.
Medical Oncology (Northwood, London, England)
|
April 28, 2022
Interim analysis of companion, prospective, phase II, clinical trials assessing the efficacy and safety of multi-modal total eradication therapy in men with synchronous oligometastatic prostate cancer
Diane K Reyes, Bruce J Trock, Phuoc T Tran, et al.
Diagnostics (Basel, Switzerland)
|
November 27, 2021
Whole-Body [<sup>18</sup>F]FDG PET/CT Can Alter Diagnosis in Patients with Suspected Rheumatic Disease
Matthias Fröhlich, Sebastian Serfling, Takahiro Higuchi, et al.
European Urology
|
March 19, 2023
Second Version of the Prostate Cancer Molecular Imaging Standardized Evaluation Framework Including Response Evaluation for Clinical Trials (PROMISE V2)
Robert Seifert, Louise Emmett, Steven P Rowe, et al.
Oncotarget
|
July 21, 2016
[64Cu]XYIMSR-06: A dual-motif CAIX ligand for PET imaging of clear cell renal cell carcinoma
Il Minn, Soo Min Koo, Hye Soo Lee, et al.
The Journal of Urology
|
February 26, 2021
A Phase 2/3 Prospective Multicenter Study of the Diagnostic Accuracy of Prostate Specific Membrane Antigen PET/CT with <sup>18</sup>F-DCFPyL in Prostate Cancer Patients (OSPREY)
Kenneth J Pienta, Michael A Gorin, Steven P Rowe, et al.
Journal of Imaging Informatics in Medicine
|
April 8, 2024
An Automated Deep Learning-Based Framework for Uptake Segmentation and Classification on PSMA PET/CT Imaging of Patients with Prostate Cancer
Yang Li, Maliha R Imami, Linmei Zhao, et al.
The Journal of Urology
|
April 15, 2021
Reply by Authors
Kenneth J Pienta, Michael A Gorin, Steven P Rowe, et al.
Page
of 51